DIFFMASTER OCTAVIA AUTOMATIC HEMATOLOGY ANALYZER

The DIFFMASTER OCTAVIA AUTOMATIC HEMATOLOGY ANALYZER by CellaVision AB utilizes advanced imaging and software algorithms to automate the morphological classification of blood cells from peripheral smears, aiming to improve laboratory efficiency and diagnostic accuracy. Clinical studies indicate the system's effectiveness, particularly with non-pathological samples, achieving an 87% preclassification accuracy for white blood cells and facilitating standardized hematological assessments.

The DIFFMASTER OCTAVIA AUTOMATIC HEMATOLOGY ANALYZER, developed by CellaVision AB, is an automated system engineered to locate and assist in the morphological classification of red and white blood cells from peripheral blood smears. Its core methodology relies on sophisticated advanced imaging technology coupled with specialized software algorithms. This combination is designed to significantly enhance the efficiency and accuracy of hematological analyses by automating the traditionally labor-intensive process of cell identification and classification, thereby streamlining laboratory workflows and reducing the potential for human error in microscopic review. Clinical evaluations of the DIFFMASTER OCTAVIA have demonstrated its effectiveness in its designated tasks, highlighted by an 87% preclassification accuracy for white blood cell analysis. The system is reported to perform optimally when processing non-pathological blood samples, delivering rapid results that support timely clinical decision-making. By integrating this technology, laboratories can promote greater consistency and standardization in hematological assessments, contributing to improved patient care through more reliable and efficient diagnostic support.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the DIFFMASTER OCTAVIA's performance in classifying pathological blood samples (e.g., those with blasts or dysplastic cells) compare to manual microscopy and other automated systems?; What specific imaging techniques and software algorithms are utilized by the DIFFMASTER OCTAVIA to achieve its reported 87% preclassification accuracy for white blood cells?; What is the system's typical throughput (samples processed per hour) and how does its integration affect overall laboratory turnaround times for differential counts?; Are there specific types of artifacts or sample conditions that can significantly impact the DIFFMASTER OCTAVIA's accuracy or ability to locate and classify cells?; What are the validation and quality control procedures recommended by CellaVision AB to ensure ongoing optimal performance and reliability of the DIFFMASTER OCTAVIA in a clinical setting?